Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01594411 · ClinicalTrials.gov registry record
PCP Use of a Gene Expression Test (Corus CAD or ASGES) in Coronary Artery Disease Diagnosis
A clinical trial, sponsored by CardioDx.
- Completed
- Registry status
- 251
- Enrollment target
NCT01594411 is a clinical trial that has completed, run by CardioDx. The registered enrollment target is 251 participants.
The verdict
NCT01594411 has completed, sponsored by CardioDx.
- COMPLETED
- Registry status
- 251 participants
- Enrollment target
Study Summary
This is a prospective, multi-center study examining the clinical impact of the Corus CAD (Age/Sex/Gene Expression score - ASGES) assay in approximately 250 evaluable subjects with no history of obstructive coronary artery disease who now present with chest pain or anginal-equivalent symptoms to a primary care physician (PCP) for evaluation.
Interventions
- DIAGNOSTIC_TEST Corus CAD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 251 participants |
| Start Date | 2012-04 |
| Est. Completion | 2013-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01594411
The ClinicalTrials.gov registry entry for NCT01594411 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 251 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CardioDx, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Corus CAD is the first listed.
NCT01594411 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01594411 about?
NCT01594411 is a clinical study titled "PCP Use of a Gene Expression Test (Corus CAD or ASGES) in Coronary Artery Disease Diagnosis". This is a prospective, multi-center study examining the clinical impact of the Corus CAD (Age/Sex/Gene Expression score - ASGES) assay in approximately 250 evaluable subjects with no history of obstructive coronary artery disease who now present with chest pain or anginal-equivalent symptoms to a pr...
What is the current status of trial NCT01594411?
This trial is currently completed. The enrollment target is 251 participants. The study started on 2012-04. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01594411?
The interventions under investigation include: Corus CAD (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT01594411?
This trial is sponsored by CardioDx, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.